CA073-1003 - A Phase 3 Multicenter Randomized Open Label Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) Vs Investigator’s Choice in Participants with Relapsed/Refractory Follicular Lymphoma (GOLSEEK4)
Learn More About This Study
